STESTERIS plc

$214.44-14% 1Y

Is the business good?

Good

A genuinely good business: 9 of 9 health tests passed, earnings fully cash-backed (1.5×), and margins widening.

3 good, 1 neutral
Fundamental health (F-score)9 / 9SEC EDGAR · Mar 31, 2026

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.52×derived · Jun 30, 2026

Operating profit is fully backed by cash. Conversion is worsening vs a year ago.

Margin direction, 3 years+2.8 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from7% ROA

A balanced mix of margins, efficiency, and leverage. ROE 10% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionmiddle of the market
Leverage (Debt/EBITDA)better than 78% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is STE?

STERIS plc earns 10% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

10%

Return on invested capital · cost of capital 9.0% · 1.5 points above what the capital costs: growth creates value

Operating margin
19%

Operating margin · Medical Devices median 2.1% · 12 months to Q1 2027

Cash conversion
1.52×

Cash conversion · 1.79× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−0.91%

Share count, year on year · flat: no meaningful dilution

Operating margin by fiscal year
YearOperating margin
FY202118%
FY202211%
FY202317%
FY202416%
FY202516%
FY202619%
Details›
Gross margin12 months to Q1 2027
44%
Operating margin12 months to Q1 2027
19%
Net margin12 months to Q1 2027
13%
Free cash flow margin
15%
R&D as % of revenue
1.9%
Revenue, trailing twelve months
$6.04B
Free cash flow, trailing twelve months
$926M
Net income, trailing twelve months
$805M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
10%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.